Global health R&D

At a glance

Funding trends

Public funding for global health research and development (R&D) stood at US$2.6 billion in 2018, according to Policy Cures Research’s G-FINDER report. This marks the third year of increasing investments in global health R&D by public donors (+9% compared to US$2.4 billion in 2017). Public funding accounted for two-thirds of total funding to the sector (64%). The remaining third came from philanthropic contributions (19%) and the private sector (17%). 

Global Health R&D General

For further details on methodology, see our Donor Tracker Codebook.

Top donors

The majority of public funding for global health R&D comes from a few donors. In 2018, the US provided two-thirds of all public funding (US$1.8 billion). The second-largest donor was the UK (US$230 million, 9% of all funding), followed by EU Institutions (US$134 million, 5%), and Germany (US$73 million, or 3%). India was the fifth-largest donor (US$66 million, 3%).


For more information, please see Policy Cures Research's 2019 G-FINDER report: 'Uneven Progress'.